Matthew  Ferguson net worth and biography

Matthew Ferguson Biography and Net Worth

CFO of Elutia
Matthew Ferguson has served as our Chief Financial Officer since September 2020. Prior to joining us, Mr. Ferguson served as Chief Financial Officer for Bossa Nova Robotics, a privately held robotics company serving major retailers, from September 2018 to July 2020. From January 2011 to August 2018, Mr. Ferguson held various management positions, including Chief Financial Officer, Chief Business Officer and Co-President, at Avinger, Inc., a publicly traded cardiovascular medical device company. From 2009 to 2010, Mr. Ferguson served as Chief Financial Officer at Tethys Bioscience, a provider of molecular diagnostic tests for cardiometabolic conditions. From 2008 to 2009, Mr. Ferguson served as the Chief Financial Officer at Proteolix, a biotechnology company developing treatments for cancer and autoimmune diseases. Mr. Ferguson also served as the Chief Financial Officer and Vice President of Finance and Business Development at FoxHollow Technologies, a publicly traded medical device company, from 2002 through its merger with ev3 in 2007. Mr. Ferguson holds an M.B.A. from the University of California at Berkeley, an M.S. in Mechanical Engineering from the University of Pennsylvania and a B.S. in Civil Engineering from Stanford University.
From 2009 to 2010, Mr. Ferguson served as Chief Financial Officer at Tethys Bioscience, a provider of molecular diagnostic tests for cardiometabolic conditions. From 2008 to 2009, Mr. Ferguson served as the Chief Financial Officer at Proteolix, a biotechnology company developing treatments for cancer and autoimmune diseases. Mr. Ferguson also served as the Chief Financial Officer and Vice President of Finance and Business Development at FoxHollow Technologies, a publicly traded medical device company, from 2002 through its merger with ev3 in 2007. Mr. Ferguson holds a B.S. in Civil Engineering from Stanford University, an M.S. in Mechanical Engineering from the University of Pennsylvania and an M.B.A. from the University of California at Berkeley.

What is Matthew Ferguson's net worth?

The estimated net worth of Matthew Ferguson is at least $73,133.55 as of December 2nd, 2022. Mr. Ferguson owns 23,217 shares of Elutia stock worth more than $73,134 as of March 28th. This net worth approximation does not reflect any other assets that Mr. Ferguson may own. Additionally, Mr. Ferguson receives a salary of $360,650.00 as CFO at Elutia. Learn More about Matthew Ferguson's net worth.

How old is Matthew Ferguson?

Mr. Ferguson is currently 56 years old. There are 3 older executives and no younger executives at Elutia. The oldest executive at Elutia is Mr. Kevin L. Rakin M.B.A, M.S., Executive Chairman, who is 63 years old. Learn More on Matthew Ferguson's age.

What is Matthew Ferguson's salary?

As the CFO of Elutia Inc., Mr. Ferguson earns $360,650.00 per year. The highest earning executive at Elutia is Dr. C. Randal Mills Ph.D., Co-Founder, President & CEO and Director, who commands a salary of $857,260.00 per year. Learn More on Matthew Ferguson's salary.

How do I contact Matthew Ferguson?

The corporate mailing address for Mr. Ferguson and other Elutia executives is 12510 Prosperity Drive, Suite 370, Silver Spring, MD 20904, United States. Elutia can also be reached via phone at 240-247-1170 and via email at [email protected]. Learn More on Matthew Ferguson's contact information.

Has Matthew Ferguson been buying or selling shares of Elutia?

Matthew Ferguson has not been actively trading shares of Elutia within the last three months. Most recently, on Monday, December 5th, Matthew Ferguson bought 22,000 shares of Elutia stock. The stock was acquired at an average cost of $4.65 per share, with a total value of $102,300.00. Following the completion of the transaction, the chief financial officer now directly owns 45,217 shares of the company's stock, valued at $210,259.05. Learn More on Matthew Ferguson's trading history.

Who are Elutia's active insiders?

Elutia's insider roster includes Thomas Englese (Insider), Matthew Ferguson (CFO), and Ronald Lloyd (CEO). Learn More on Elutia's active insiders.

Matthew Ferguson Insider Trading History at Elutia

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/5/2022Buy22,000$4.65$102,300.0045,217View SEC Filing Icon  
12/2/2022Buy6,000$4.03$24,180.0023,217View SEC Filing Icon  
5/10/2021Buy1,300$11.14$14,482.001,300View SEC Filing Icon  
See Full Table

Matthew Ferguson Buying and Selling Activity at Elutia

This chart shows Matthew Ferguson's buying and selling at Elutia by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Elutia Company Overview

Elutia logo
Elutia Inc., a commercial-stage company, engages in developing and commercializing drug-eluting biomatrix technology to enhance surgical outcomes. It offers CanGaroo Envelope, which is used for the stabilization of implantable cardiac devices, such as pacemakers and defibrillators. The company also engages in the development of CanGaroo RM for delivery directly to the surgical site. In addition, it offers SimpliDerm Acellular Dermal Matrix used primarily in breast reconstruction following mastectomy. The company was formerly known as Aziyo Biologics, Inc. and changed its name to Elutia Inc. in September 2023. Elutia Inc. was incorporated in 2015 and is headquartered in Silver Spring, Maryland.
Read More

Today's Range

Now: $3.15
Low: $3.15
High: $3.24

50 Day Range

MA: $3.56
Low: $2.82
High: $4.07

2 Week Range

Now: $3.15
Low: $1.10
High: $4.19

Volume

3,001 shs

Average Volume

24,511 shs

Market Capitalization

$76.45 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.54